-
PROVIDERS
Read more
Browse our latest selection of abstracts, manuscripts, and presentations.
- LIFE SCIENCES
-
PATIENTS
It's About Time
View the Tempus vision.
- RESOURCES
-
ABOUT US
View Job Postings
We’re looking for people who can change the world.
Original Webinar Date:
06/29/2021
Tumor-normal matched sequencing and platforms utilized for tumor profiling
The Evolving Role of NGS and Germline Sequencing in Patients with Advanced and Metastatic Cancer - Episode 2
Speakers
Mark E. Robson, MD, Memorial Sloan Kettering Cancer Center, John Henson, MD, Augusta University, Ashley Ross, MD, PhD, Northwestern Medicine, Dana Farengo Clark, MS, LCGC, Penn Medicine
Mark Robson, MD, reviews data from a recent abstract on incidental germline findings detected by tumor-normal matched sequencing and the panelists share which platforms they utilize for tumor profiling.
Watch the Webinar Here-
04/15/2024Identifying patients with Valvular Heart Disease: A partnership between a specialty designated cardiac center and Tempus
Learn how the deployment of Tempus Next, an AI-enabled clinical care pathway solution, at a specialty designated cardiac and heart valve center helped enable guideline directed care for patients with structural heart disease.
Read more -
04/15/2024Closing the biomarker testing gap for early stage NSCLC patients with Tempus Next
Learn how Tempus Next was deployed at TriHealth Cancer and Blood Institute in Cincinnati, Ohio to surface and close gaps in biomarker testing for NSCLC patients.
Read more -
12/19/2023Streamlining clinical trial operational overhead at a multi-location, community-based cancer care center
The Oncology Institute of Hope and Innovation (TOI) highlights how the Tempus TIME program amplified the ability to identify the right patient for the right study at the right time, while reducing the time and resources needed to open new clinical trials.
Read more